🔎 Trials Near Me

Gara Jalqabaatti › Myasthenia Gravis › Texas › Austin

Qorannoo klinikaalii Myasthenia Gravis Austin, TX keessatti

Qorannoo 6 Myasthenia Gravis f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

Namoota walitti qabaa jiraSadarkaa 2
  • Austin Neuromuscular Center, Austin
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06987539

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

Namoota walitti qabaa jiraSadarkaa 3
  • Austin Neuromuscular Center, Austin
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07217587

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Namoota walitti qabaa jiraSadarkaa 2
  • National Neuromuscular Research Institute, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07673627

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Namoota walitti qabaa jiraQorannoo ilaalaa
  • National Neuromuscular Research Institute, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07294170

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Namoota walitti qabaa jiraSadarkaa 2
  • National Neuromuscular Research Institute, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07284420

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Namoota walitti qabaa jiraQorannoo ilaalaa
  • National Neuromuscular Research Institute, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT06298565

Qorannoo Myasthenia Gravis magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.